REQUEST A DEMO
Total
USD $0.00
Search more companies

Kentfarma Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Kentfarma Ilac Anonim Sirketi Profile Updated: March 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Kentfarma Ilac A.S. is a company in Turkiye, with a head office in Istanbul. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on November 05, 2012. The total number of employees is currently 6 (2024). In its most recent financial highlights, the company reported a net sales revenue increase of 96.71% in 2022. During that time, Kentfarma Ilac A.S.’s total assets grew by 176.27%.

Headquarters
No:9-2 Kavacik Mahallesi Sehit Albay Suat Karadag Sokak Beykoz
Istanbul; Marmara; Postal Code: 34810

Contact Details: Purchase the Kentfarma Ilac A.S. report to view the information.

Website: http://www.kentfarma.com

Basic Information
Total Employees:
Purchase the Kentfarma Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Kentfarma Ilac A.S. report to view the information.
Incorporation Date:
November 05, 2012
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Kentfarma Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
96.71%
Total operating revenue
96.71%
Operating profit (EBIT)
434.71%
Net Profit (Loss) for the Period
N/A
Total assets
176.27%
Total equity
232.93%
Operating Profit Margin (ROS)
8.42%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-552.56%
Quick Ratio
-0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?